Looking forward to presenting at @Eyecelerator during this week’s annual meeting…
[ad_1]
Looking forward to presenting at @Eyecelerator during this week’s annual meeting of the @aao_ophth! Now, #clinicaltrials involving suprachoroidal delivery include a tyrosine kinase inhibitor, a corticosteroid, a #genetherapy & a virus-like drug conjugate
https://t.co/qgyOQb2YzJ
[ad_2]
Source by Thomas Ciulla, MD, MBA